You are here: Industry Insights > neurodegenerative

News List

Nurosene, Cyclica partner for neurodegenerative disease drug development pharmaceutical-business-review
February 11, 2022
Nurosene, Cyclica partner for neurodegenerative disease drug development.
Regenxbio, Neurimmune to Develop Antibodies for Neurodegenerative Disease Treatment contractpharma
July 26, 2019
Potential to deliver sustained levels of therapeutic human antibodies to the brain with AAV vectors.
Important Finding by Chinese Scientists: Vitamin B12 is Expected to Treat PD PharmaSources/Yefenghong
May 06, 2019
Parkinson’s disease (PD) is the second most common neurodegenerative disease after Alzheimer's disease, which affects about 1% population in the world. PD patients may continue to increase as society develops and the aging of the population becomes increa
NIH study implicates hyperactive immune system in aging brain disorders biospectrumasia
January 07, 2019
In a study of fruit flies, NIH scientists suggested that the body’s immune system may play a critical role in the damage caused by aging brain disorders.
Neurimmune, Ono Pharmaceutical Collaborate in Neurodegenerative Diseases Field americanpharmaceuticacreview
November 10, 2017
Neurimmune has entered into a collaboration with Ono Pharmaceutical focused on the development of human antibodies against a novel therapeutic target for neurodegenerative diseases.
Early-stage study gives hope for rare and fatal neurodegenerative condition pharmafile
August 14, 2017
A team of researchers at Washington University School of Medicine (WUSM) in St Louis and the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health (NIH) have revealed the promising ...